SCHEMBL2923255

SCHEMBL2923255

OCCCCNO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333641 0.97
SCHEMBL7060166 0.97
SCHEMBL7095523 0.97 CA1 (0.44)
SCHEMBL7095924 0.97 CA1 (0.44)
SCHEMBL7099996 0.97 CA1 (0.44)
SCHEMBL6898679 0.97 CA1 (0.44)
SCHEMBL22973178 0.97 CA1 (0.44)
Hydrochloric Acid SCHEMBL2922312 0.97
SCHEMBL3676628 0.89
Hydrochloric Acid SCHEMBL4799757 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4602020-A1 ANTIPOLYMERANT COMPOSITIONS WITH NAPHTHOQUINONE AND HYDROXYLAMINE AND METHODS OF USING Ecolab USA, Inc. (US) 2025-08-20 EP claimed
US-20240141131-A1 ANTIPOLYMERANT COMPOSITIONS WITH NAPHTHOQUINONE AND HYDROXYLAMINE AND METHODS OF USING ECOLAB USA INC. 2024-05-02 US claimed
WO-2024081354-A1 ANTIPOLYMERANT COMPOSITIONS WITH NAPHTHOQUINONE AND HYDROXYLAMINE AND METHODS OF USING ECOLAB USA INC. (US) 2024-04-18 WO claimed
US-20040110729-A1 Primary N-hydroxylamines NIH 2004-06-10 US claimed
US-6455589-B1 AN ORALLY ADMINISTRABLE EFFECTIVE UNIT SOLID DOSAGE OF A PRIMARY N-HYDROXYLAMINE OR A SALT, FREE OF NITRONE; USEFUL FOR REDUCING OXIDATIVE DAMAGE OR DELAYING SENESCENCE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-09-24 US claimed
WO-2001030979-A1 PRIMARY N-HYDROXYLAMINES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-05-03 WO claimed
US-5282957-A Methods for inhibiting polymerization of hydrocarbons utilizing a hydroxyalkylhydroxylamine BETZ LABORATORIES, INC. (US) 1994-02-01 US claimed
EP-4602020-A1 ANTIPOLYMERANT COMPOSITIONS WITH NAPHTHOQUINONE AND HYDROXYLAMINE AND METHODS OF USING Ecolab USA, Inc. (US) 2025-08-20 EP disclosed
US-20240141131-A1 ANTIPOLYMERANT COMPOSITIONS WITH NAPHTHOQUINONE AND HYDROXYLAMINE AND METHODS OF USING ECOLAB USA INC. 2024-05-02 US disclosed
CN-116693406-B Preparation method of salbutamol sulfate 山东锐顺药业有限公司 2024-04-19 CN disclosed
WO-2024081354-A1 ANTIPOLYMERANT COMPOSITIONS WITH NAPHTHOQUINONE AND HYDROXYLAMINE AND METHODS OF USING ECOLAB USA INC. (US) 2024-04-18 WO disclosed
CN-116693406-A Preparation method of salbutamol sulfate 山东锐顺药业有限公司 2023-09-05 CN disclosed
EP-3053600-A1 CYTOTOXIC BENZODIAZEPINE DERIVATIVES ImmunoGen, Inc. (US) 2016-08-10 EP disclosed
US-20020099211-A1 9-alkylamino-1-nitroacridine derivatives NEW YORK MEDICAL COLLEGE 2002-07-25 US disclosed
US-20020037831-A1 1-Nitroacridine/tumor inhibitor compositions TIWARI RAJ (US) 2002-03-28 US disclosed
WO-2001060801-A2 9-ALKYLAMINO-1-NITROACRIDINE DERIVATIVES NEW YORK MEDICAL COLLEGE (US) 2001-08-23 WO disclosed
WO-2001060351-A2 NITROACRIDINE/TUMOR INHIBITOR COMPOSITIONS NEW YORK MEDICAL COLLEGE (US) 2001-08-23 WO disclosed
EP-0505633-B1 Hydroxyalkylhydroxylamine oxygen scavengers for use in aqueous media BETZ EUROP INC (US) 1994-12-07 EP disclosed
US-5282957-A Methods for inhibiting polymerization of hydrocarbons utilizing a hydroxyalkylhydroxylamine BETZ LABORATORIES, INC. (US) 1994-02-01 US disclosed
EP-0505633-A1 Hydroxyalkylhydroxylamine oxygen scavengers for use in aqueous media BETZ EUROPE, INC. (US) 1992-09-30 EP disclosed